The University of California, Irvine is seeking applicants for the position of Director, Early Phase Clinical Trials & Precision Therapeutics. The Director will be responsible for the development and growth of UCI’s early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center’s (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (Alpha Clinic).
This position will report to the CFCCC Director and the UCI School of Medicine Vice Dean for Clinical Research. The incumbent will be a member of the oversight committees for the Stern Center, CCR, and Alpha Clinic and will maintain regular communication with School of Medicine leadership (Dean, Vice Deans, Institute for Clinical and Translational Science director, and clinical Chairs) and other key stakeholders (e.g., CFCCC Internal Advisory Board, External Advisory Board, CCR, and AC Advisory Boards). The home department appointment will be in whichever is most appropriate for the selected candidate.
Specific Responsibilities:
· Develop and lead a coordinated Phase I program for cooperative group, industry, and institutional/investigator-initiated clinical trials across all therapeutic areas
· Oversee, encourage, facilitate, and maximize enrollment on Phase I trials across disease sites and various Departments
· Create, ensure and maintain critical contacts with industry partners
· Work with institutional leadership across the three research entities (CFCCC Associate Director for Translational Science, Stern Center Medical Director, CCR Medical Director, AC Medical Director) to promote the translation of scientific discoveries toward the clinic through interactions with the various clinical research units at UCI
· With the Department of Pathology and Laboratory Medicine, create and develop the infrastructure to support a regularly held molecular tumor board or equivalent
· Ensure sufficient support levels for clinical/translational research including regulatory approval processes, biospecimen collection, and clinical research coordination; in short, all aspects of the clinical/translational research effort
· Ensure an efficient infrastructure for formulation, launch, and completion of investigator-initiated early-phase clinical trials
· Facilitate early phase clinical trials designed to maximize the development of cutting-edge therapies
· Promote rapid progress by the Early Phase Clinical Trials Unit in cancer immunotherapy
Qualifications:
· MD, MD/PhD degree or equivalent
· Academic credentials which could merit appointment at the rank of Associate Professor or Professor in the Ladder Rank or Clinical X series
We desire applicants who have evidence of commitment to or strong potential for commitment to the advancement of diversity, equity, and inclusion for underrepresented minority students and groups (Black/African-American, Latino(a)/Chicano(a)/Hispanic, and Native American).
Application Procedures:
Applicants should contact the Grant Cooper Team, reaching out to Rachel Charney,
[email protected] To apply, please log onto UC Irvine’s recruitment site located at
https://recruit.ap.uci.edu/JPF09351. Review of applications will continue until the position is filled.
The salary range for this position is $300,000 - $358,513.50. The posted UC salary scales set the minimum pay determined by rank and step at appointment.
Job location: Irvine, CA